Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Arimoclomol citrate

EU orphan designation number: EU/3/16/1659   
Active ingredient: Arimoclomol citrate
Indication: Treatment of inclusion body myositis
Sponsor: Orphazyme ApS
c/o COBIS A/S, Ole Maaløes Vej 3, 2200 København N, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/06/2016 Orphan designation EMA/OD/256/15 (2016)3414 of 30/05/2016